Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522948 · ClinicalTrials.gov registry record · NA
Alcohol and Sex Risk Intervention for MSM Supplement
A NA study of Heavy Drinking and Sexual Risk Behavior, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03522948: Completed NA study of Heavy Drinking and Sexual Risk Behavior, sponsored by Boston University Charles River Campus.
NCT03522948 is a NA study of Heavy Drinking and Sexual Risk Behavior that has completed, run by Boston University Charles River Campus. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03522948, a NA study of Heavy Drinking and Sexual Risk Behavior, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Open pilot trial to test the feasibility and efficacy of a brief intervention with text messaging to reduce sexual risk behavior and heavy drinking among MSM
Primary Outcome
3-item modification of Client Satisfaction Questionnaire. Three 5-point Likert scale is used to assess "intervention satisfaction" \[very dissatisfied - very satisfied\]; degree to which intervention helped alcohol use \[no effect to helped a great deal\], and intervention helped sexual behavior decisions \[no effect - helped a great deal\]. Mean scale range is 1-5. Higher scores reflect a better outcome
Conditions Studied
Interventions
- BEHAVIORAL Brief intervention with text messaging to reduce sexual risk and heavy drinking among MSM
Study Locations (1)
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2018-05-17 |
| Phase | NA |
What the finished NCT03522948 record still lists
NCT03522948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Heavy Drinking and Sexual Risk Behavior appearing as the primary indexed condition, and to 1 intervention - of which Brief intervention with text messaging to reduce sexual risk and heavy drinking among MSM is the first listed.
NCT03522948 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03522948 about?
NCT03522948 is a clinical study titled "Alcohol and Sex Risk Intervention for MSM Supplement". Open pilot trial to test the feasibility and efficacy of a brief intervention with text messaging to reduce sexual risk behavior and heavy drinking among MSM
What is the current status of trial NCT03522948?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-11-07. Estimated completion is 2018-05-17.
What conditions does trial NCT03522948 study?
This clinical trial studies the following conditions: Heavy Drinking and Sexual Risk Behavior.
What interventions are being tested in trial NCT03522948?
The interventions under investigation include: Brief intervention with text messaging to reduce sexual risk and heavy drinking among MSM (BEHAVIORAL).
Who is sponsoring clinical trial NCT03522948?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03522948 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03522948's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI